PedAM
Pediatric Disease Annotations & Medicines
| Disease | artery disease |
| Phenotype | C0021775|intermittent claudication |
| Sentences | 12 |
| PubMedID- 25316347 | Conclusions: despite evidence to support benefits of dietary modification in risk reduction of peripheral artery disease, adults with intermittent claudication continue to consume poor diets. |
| PubMedID- 25700732 | Objectives: to explore the experiences of individuals living with intermittent claudication (ic) owing to peripheral artery disease (pad), their knowledge about the condition, and their thoughts about being asked to walk more and an intervention to promote walking. |
| PubMedID- 22444105 | Background: while intermittent claudication is the hallmark of symptomatic peripheral artery disease, most patients with peripheral artery disease have atypical symptoms. |
| PubMedID- 26280273 | intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches. |
| PubMedID- 22051985 | Aim: the aim of this paper was to determine the prevalence of extracraneal carotid artery disease in patients with intermittent claudication, to describe classic cardiovascular risk factors in those with hemodynamically significant stenosis and to try to define subgroups at high risk, improving therefore the performance of non invasive testing. |
| PubMedID- 21572574 | Wilson et al78 conducted a randomized clinical trial of oral l-arginine vs placebo for 6 months in patients with intermittent claudication due to peripheral artery disease. |
| PubMedID- 21262997 | Background: this prospective, randomized, controlled clinical trial compared changes in exercise performance and daily ambulatory activity in peripheral artery disease patients with intermittent claudication after a home-based exercise program, a supervised exercise program, and usual-care control. |
| PubMedID- 20574137 | Long-term clinical outcome after endovascular treatment in patients with intermittent claudication due to iliofemoral artery disease. |
| PubMedID- 20385711 | Pharmacologic therapy for intermittent claudication in patients with peripheral artery disease (pad) is limited. |
| PubMedID- 24565471 | The exclusion criteria included: prior cardiovascular disease (cvd) (including coronary heart disease [angina, myocardial infarction, coronary revascularization procedures or existence of abnormal q waves in the electrocardiogram], stroke [either ischemic or hemorrhagic, including transient ischemic attacks], or clinical peripheral artery disease with symptoms of intermittent claudication), prevalent diabetes or treatment with insulin or oral hypoglycemic drugs, immunodeficiency or hiv-positive status, illegal drug use or chronic alcoholism, and/or body mass index (bmi) >40 kg/m2. |
| PubMedID- 25100750 | We verified whether vascular reactivity is impaired and whether there is any association between vascular reactivity, walking ability, and peripheral artery disease (pad) severity in patients with intermittent claudication (ic). |
| PubMedID- 26245919 | Primary self-expanding nitinol stenting vs balloon angioplasty with optional bailout stenting for the treatment of infrapopliteal artery disease in patients with severe intermittent claudication or critical limb ischemia (expand study). |
Page: 1